COMMUNIQUÉS West-GlobeNewswire

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
09/05/2024
MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today [...]
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
09/05/2024
THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s [...]
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
09/05/2024
Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) notes that its partner Neurocrine Biosciences Inc. (“Neurocrine”; Nasdaq: NBIX), a leading neuroscience-focused [...]
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024
09/05/2024
Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2024 [...]
Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting
09/05/2024
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 09 May 2024, 07:00 CEST Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting [...]
argenx Reports First Quarter 2024 Financial Results and Provides Business Update
09/05/2024
$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 [...]
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
09/05/2024
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
09/05/2024
Announces Plan for $20 million in Aggregate New Financing to Support Daily Operations, Restructuring, Strategic Initiatives, and Advocacy Company Enters into Voluntary Chapter 11 Restructuring Process Which Will Take [...]
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
09/05/2024
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches based on [...]
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
08/05/2024
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
08/05/2024
Company acquired all assets for the synergistic CNSide cerebrospinal fluid diagnostic portfolio Company will summarize topline data from the FORESEE clinical trial planned for presentation at the SNO/ASCO Meeting in [...]
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
08/05/2024
NEW YORK and WALTHAM, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
08/05/2024
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences: BofA Securities Health Care [...]
STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year
08/05/2024
Total fiscal 2024 revenue increased 12% to $5.5 billion Total fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83 Targeted restructuring plan announced [...]
SCYNEXIS Reports First Quarter 2024 Financial Results and Provides Corporate Update
08/05/2024
SCY-247’s IND-enabling activities continue to progress, with initiation of Phase I anticipated in the second half of 2024 Clinical study reports for the FURI, CARES and NATURE trials in refractory invasive fungal [...]
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
08/05/2024
Conference Call to Begin Today at 5:00 p.m. (ET) 1Q 2024 Total revenues of $66M; +63% vs. 1Q 2023 1Q 2024 Net income of $11M; Non-GAAP net income of $15M $304M of cash and cash equivalents and investments at March 31, [...]
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
08/05/2024
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products FIRDAPSE® Q1 2024 Net Product Revenues of $66.8 Million, a 16.2% [...]
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
08/05/2024
Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trial Zeno BLA accepted for priority review by the FDA for the [...]
Dentsply Sirona to Participate in Upcoming Investor Conferences
08/05/2024
CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. Bank of America 2024 Health Care [...]

Pages